www.fdanews.com/articles/83268-enanta-pharmaceuticals-achieves-milestone-in-alliance-with-shionogi-co-ltd
ENANTA PHARMACEUTICALS ACHIEVES MILESTONE IN ALLIANCE WITH SHIONOGI & CO., LTD.
December 20, 2005
Enanta Pharmaceuticals today announced that it has received a milestone payment from its East Asia development and commercialization partner, Shionogi & Co., Ltd., as Phase 2 studies have initiated in Japan for its community antibiotic, EDP-420 (formerly known as EP-013420, and known in Japan as S-013420).
Yahoo News (http://biz.yahoo.com/prnews/051220/netu018.html?.v=39)